Stockscreener 앱 받기
277.00
0.86%
-2.39
시장 영업 전:
302.90
25.90
+9.35%
전일 마감가:
$279.39
열려 있는:
$277.38
하루 거래량:
1.21M
Relative Volume:
1.80
시가총액:
$19.92B
수익:
$2.96B
순이익/손실:
$487.70M
주가수익비율:
41.49
EPS:
6.6758
순현금흐름:
$344.00M
1주 성능:
+5.34%
1개월 성능:
+9.82%
6개월 성능:
+28.76%
1년 성능:
-3.28%
1일 변동 폭
$276.02
$283.54
1주일 범위
$260.12
$283.54
52주 변동 폭
$187.43
$352.33
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
WST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
277.00 | 20.09B | 2.96B | 487.70M | 344.00M | 6.6758 |
|
ISRG
Intuitive Surgical Inc
|
527.03 | 165.88B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
188.11 | 54.18B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
266.48 | 39.14B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
76.40 | 37.46B | 10.03B | 1.07B | 1.39B | 2.1549 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-15 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
West Pharmaceutical Services Reports Strong Q3 2025 Results - TipRanks
West Pharmaceutical Services, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
West Pharmaceutical Services (NYSE:WST) Releases FY 2025 Earnings Guidance - MarketBeat
Form 8-K WEST PHARMACEUTICAL SERV For: Oct 23 - StreetInsider
West Pharmaceutical: Q3 Earnings Snapshot - News-Times
West Pharmaceutical Services Q3 Non-GAAP Earnings, Revenue Rise; Increases 2025 Guidance - MarketScreener
West Pharmaceutical Services Inc. Q3 Profit Increases, Beats Estimates - Nasdaq
West Pharmaceutical beats Q3 net sales estimates; lifts FY revenue, EPS outlook - MarketScreener
West Pharmaceutical surges 3% on strong Q3 results, raised guidance By Investing.com - Investing.com Canada
West Pharmaceutical Services’s (NYSE:WST) Q3 Sales Beat Estimates - Yahoo Finance
(WST) West Pharmaceutical Services, Inc. Expects Q4 Revenue Range $790.0M$800.0M - MarketScreener
Earnings Flash (WST) West Pharmaceutical Services, Inc. Reports Q3 Revenue $804.6M, vs. FactSet Est of $785.7M - MarketScreener
West Pharma Lifts Outlook As Drug Demand Drives Growth - Finimize
West Reports Third-Quarter 2025 Results - Yahoo Finance
Atria Wealth Solutions Inc. Cuts Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
How sustainable is West Pharmaceutical Services Inc. stock dividend payoutExit Point & Reliable Price Breakout Alerts - newser.com
Can West Pharmaceutical Services Inc. stock surprise with quarterly resultsWeekly Trade Recap & Community Verified Trade Signals - newser.com
Birch Hill Investment Advisors LLC Buys New Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
How West Pharmaceutical Services Inc. stock responds to bond marketJuly 2025 Breakouts & Free Reliable Trade Execution Plans - newser.com
How West Pharmaceutical Services Inc. stock valuation compares with sectorJuly 2025 Short Interest & Long-Term Growth Plans - newser.com
Is West Pharmaceutical Services Inc. stock testing key supportPortfolio Performance Summary & Short-Term Swing Trade Alerts - newser.com
West Pharmaceutical Services, Inc. $WST Stock Position Lifted by Whittier Trust Co. - MarketBeat
West Pharmaceutical Services (WST) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Will West Pharmaceutical Services Inc. see short term momentumMarket Performance Summary & Real-Time Stock Entry Alerts - newser.com
How to integrate West Pharmaceutical Services Inc. into portfolio analysis tools2025 Analyst Calls & Reliable Trade Execution Plans - newser.com
What does recent volatility data suggest for West Pharmaceutical Services Inc.Analyst Downgrade & Free Reliable Trade Execution Plans - newser.com
Why West Pharmaceutical Services Inc. stock could rally in 2025Quarterly Profit Review & Real-Time Buy Signal Alerts - newser.com
West Pharmaceutical Services Inc (WST)'s Winning Formula: Financ - GuruFocus
Is West Pharmaceutical Services Inc. stock bottoming outJuly 2025 Macro Moves & Capital Protection Trading Alerts - newser.com
West Pharmaceutical Services: HVP Moat Cum GLP-1 And Biologics Tailwinds Reinforce Upward Momentum - Seeking Alpha
West Pharmaceutical Services, Inc. $WST Shares Bought by Sequoia Financial Advisors LLC - MarketBeat
Published on: 2025-10-20 21:22:39 - newser.com
Will West Pharmaceutical Services Inc. stock keep high P E multiplesJuly 2025 Recap & Free Fast Gain Swing Trade Alerts - newser.com
West Pharmaceutical Services to Report Third-Quarter 2025 Results October 23 - MSN
Is West Pharmaceutical Services Inc. (WPS) stock overpriced at current multiplesEarnings Risk Summary & Community Shared Stock Ideas - nchmf.gov.vn
Risk Off: How West Pharmaceutical Services Inc. stock valuation compares with sectorJuly 2025 Momentum & Low Risk High Win Rate Stock Picks - nchmf.gov.vn
Retail Surge: How West Pharmaceutical Services Inc. stock responds to bond marketJuly 2025 Sentiment & High Return Trade Guides - nchmf.gov.vn
Will West Pharmaceutical Services Inc. stock gain from lower interest ratesIndex Update & Free Technical Confirmation Trade Alerts - newser.com
Improved Investor Confidence Boosted West Pharmaceutical Services (WST) - Insider Monkey
West Pharmaceutical Services (WST) Stock Analysis: Exploring the 17.98% Potential Upside for Investors - DirectorsTalk Interviews
West Pharmaceutical Services, Inc. $WST Shares Bought by Conestoga Capital Advisors LLC - MarketBeat
Using fundamentals and technicals on West Pharmaceutical Services Inc.CPI Data & Accurate Technical Buy Alerts - newser.com
William Blair Investment Management LLC Purchases 13,314 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.07%
0.79%
자본화:
|
볼륨(24시간):